1,2,3-triazolyl-C-核化物的化学和生物学发展

Sarah Moreira Rodrigues do Nascimento1, Angélique Ferry2,3, Florian Gallier2,3

  • 1Biocatalysis and Organic Synthesis Group, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Archiv der Pharmazie
|December 27, 2023
PubMed
概括

1,2,3-Triazolyl-C-核化物,从利巴维林改性,显示作为广谱抗病毒药物和抗癌剂的承诺. 它们的C-C键稳定性为新药开发提供了改进的药理学特征.